AstraZeneca upbeat on Wilson disease trial, Forxiga approval
26th Aug 2021 07:21
(Sharecast News) - AstraZeneca said on Thursday that positive high-level results from the 'FoCus' phase 3 trial in Wilson disease showed 'ALXN1840' met the primary endpoint, with a statistically significant improvement in daily mean copper mobilisation from tissues, demonstrating superiority compared with standard-of-care treatments.
Read moreAstraZeneca Covid antibody combination meets primary endpoint
20th Aug 2021 09:05
(Sharecast News) - AstraZeneca said on Friday that an antibody combination modified to potentially provide long-lasting protection against Covid-19 has met its primary endpoint in a trial.
Read moreAstraZeneca ends ALS trial on committee recommendation
20th Aug 2021 09:02
(Sharecast News) - AstraZeneca announced on Friday that its rare disease division Alexion is discontinuing 'CHAMPION-ALS', the global phase 3 clinical trial of 'Ultomiris', or ravulizumab, in adults with amyotrophic lateral sclerosis (ALS).
Read morePfizer and AstraZeneca vaccines less effective versus Delta, large UK study finds
19th Aug 2021 10:52
(Sharecast News) - The Delta variant of Covid-19 blunts the efficacy of the Pfizer-BioNTech and AstraZeneca vaccines, the results of one of the largest real-world studies revealed.
Read moreSunday newspaper round-up: Meggitt, GlaxoSmithKline, Luxury goods
15th Aug 2021 17:08
(Sharecast News) - Ministers must be prepared to block a takeover of Meggitt if any bidder tries to buy it without giving binding commitments on investment and jobs, the FTSE 250 aerospace and defence manufacturer's chairman warned this weekend. Sir Nigel Rudd said that while "clearly, price is important", any new owner would need to give Meggitt and the government undertakings, including to keep the company's headquarters in Coventry and maintain R&D spending. - Sunday Times
Read moreJP Morgan restarts AstraZeneca at overweight, sees re-rating opportunity
12th Aug 2021 12:11
(Sharecast News) - Analysts at JP Morgan resumed their coverage of AstraZeneca at 'overweight', telling clients they saw a "re-rating opportunity".
Read moreThursday broker round-up
12th Aug 2021 12:09
(Sharecast News) - Hill&Smith: Berenberg keeps at buy and raises target price from 1,775.0p to 1,995.0p.
Read moreAstraZeneca gets another approval for 'Forxiga'
9th Aug 2021 07:35
(Sharecast News) - AstraZeneca announced on Monday that 'Forxiga', or dapagliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor, has been approved in the European Union for the treatment of chronic kidney disease (CKD) in adults with and without type-2 diabetes.
Read moreAstraZeneca's Saphnelo receives FDA approval
2nd Aug 2021 08:07
(Sharecast News) - Drugmaker AstraZeneca said on Monday that Saphnelo had been approved in the US for the treatment of adult patients already receiving standard therapy for moderate to severe systemic lupus erythematosus.
Read moreAstraZeneca boss not yet sure if booster shots will be needed
29th Jul 2021 14:48
(Sharecast News) - AstraZeneca does not know yet whether so-called 'booster' shots of its Covid-19 vaccine will be needed or not.
Read moreAstraZeneca lifts EPS guidance as H1 revenues jump
29th Jul 2021 08:07
(Sharecast News) - AstraZeneca posted a jump in first-half revenue on Thursday as it updated its guidance to include recently-acquired Alexion Pharmaceuticals.
Read moreIMF calls for rapid action to increase access to Covid-19 vaccines
27th Jul 2021 15:19
(Sharecast News) - The International Monetary Fund's chief economist called on world governments to improve low-and-middle income countries' access to vaccines in order to avoid downside risks.
Read moreAstraZeneca's 'Ultomiris' gets EU approval for use in children
26th Jul 2021 07:25
(Sharecast News) - AstraZeneca said on Monday that 'Ultomiris', or ravulizumab, has been recommended for marketing authorisation in the European Union for expanded use, to include children and adolescents with paroxysmal nocturnal haemoglobinuria (PNH).
Read moreJefferies believes Delta may be less lethal than other variants
20th Jul 2021 09:42
(Sharecast News) - Analysts at Jefferies believe the so-called Delta variant may be less lethal, even if more transmissible, than earlier variants of the virus.
Read moreAstraZeneca lung cancer drug approved in China
19th Jul 2021 07:52
(Sharecast News) - Pharmaceutical company AstraZeneca said its drug to treat extensive-stage small cell lung cancer had been approved in China.
Read more